Shares of Alnylam Pharmaceuticals (ALNY - Get Report) plunged Thursday after the biopharmaceutical company stopped development of its drug to treat hereditary conditions that can lead to nerve and heart damage. A late-stage study of the treatment determined that more patients died after receiving the drug than receiving a placebo. About half of Alnylam's market cap has vanished on the announcement
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Video
Self-Employed? Here's How to Save Up to $62,000 a Year for Retirement
If you're self-employed, here's how you can sock away up to $62,000 per year in your nest egg.